BM 301
Latest Information Update: 12 Feb 2001
At a glance
- Originator BioMarin Pharmaceutical
- Class Antifungals
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Aspergillosis
Most Recent Events
- 12 Feb 2001 Discontinued-Preclinical for Aspergillosis in USA (Unknown route)
- 30 Oct 2000 New profile
- 30 Oct 2000 Preclinical development for Aspergillosis in USA (Unknown route)